Voglicap M 500mg/0.2mg Tablet SR
Marketer
Cappeline Pharmaceuticals Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Voglicap M 500mg/0.2mg Tablet SR
Diabeticap SR 500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Diabeticap SR should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. Potential side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes; these are usually transient and self-limiting. Consult your physician if these persist or cause concern; management strategies may be available. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Voglicap M 500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Voglicap M 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglicap M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglicap M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
Common Side effects of Voglicap M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglicap M 500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglicap M 500mg/0.2mg Sustained-Release tablets should be administered with a meal.
How Voglicap M 500mg/0.2mg Tablet SR works:
Voglicap M 500mg/0.2mg extended-release tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglicap M 500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Voglicap M 500mg/0.2mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglicap M 500mg/0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Voglicap M 500mg/0.2mg tablets typically do not impair driving ability. Nevertheless, individuals taking this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Exercise caution when administering Voglicap M 500mg/0.2mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Voglicap M 500mg/0.2mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Voglicap M 500mg/0.2mg sustained-release tablets to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Voglicap M 500mg/0.2mg Tablet SR :
Should you forget a Voglicap M 500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Voglicap M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently